Palbociclib combined with endocrine treatment in hormone receptor-positive, HER2-negative breast cancer patients with high relapse risk after neoadjuvant chemotherapy: subgroup analyses of premenopausal patients in PENELOPE-B
在接受新辅助化疗后复发风险高的激素受体阳性、HER2阴性乳腺癌患者中，帕博西尼联合内分泌治疗：PENELOPE-B研究中绝经前患者的亚组分析
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2024.103466
Marmé, F; Martin, M; Untch, M; Thode, C; Bonnefoi, H; Kim, S-B; Bear, H; Mc Carthy, N; Gelmon, K; García-Sáenz, J A; Kelly, C M; Reimer, T; Valota, O; Toi, M; Rugo, H S; Gnant, M; Makris, A; Bassy, M; Zhang, Z; Furlanetto, J; Nekljudova, V; Loibl, S
